Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis
A Multicenter, Randomized, Controlled Study to Compare the Efficacy and Safety of 2 Types of Drug Eluting Balloon Catheters (RESTORE DEB and SeQuent® Please) in Chinese Patient With Coronary In-stent Restenosis (ISR)
Sponsor: R&G Pharma Studies Co.,Ltd.
This NA trial investigates Coronary Restenosis and is currently completed. R&G Pharma Studies Co.,Ltd. leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2019 — Jan 2021 [monthly]
Completed NA
-
Aug 2018 — Aug 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 3 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- R&G Pharma Studies Co.,Ltd.
- ZhuHai Cardionovum Medical Device Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .